GMVDF (G Medical Innovations Holdings) EBIT: $-9.86 Mil (TTM As of Dec. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GMVDF G Medical Innovations Holdings Ltd GMVDF
12 GF Score
Price $0.00
View Full Analysis

What is G Medical Innovations Holdings EBIT?

G Medical Innovations Holdings GMVDF 12 EBIT is $-9.86 Mil as of Dec. 2022. GuruFocus rates GMVDF with a GF Score™ of 12/100.

G Medical Innovations Holdings's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2022 was $-1.00 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2022 was $-9.86 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. G Medical Innovations Holdings's annualized ROC % for the quarter that ended in Dec. 2022 was -179.25%. G Medical Innovations Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was -59.69%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

G Medical Innovations Holdings  (OTCPK:GMVDF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

G Medical Innovations Holdings's annualized ROC % for the quarter that ended in Dec. 2022 is calculated as:

ROC % (Q: Dec. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2022 ) + Invested Capital (Q: Dec. 2022 ))/ count )
=-13.242 * ( 1 - 0% )/( (9.516 + 5.259)/ 2 )
=-13.242/7.3875
=-179.25 %

where

Invested Capital(Q: Jun. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=10.278 - 5.457 - ( 1.509 - max(0, 10.613 - 5.918+1.509))
=9.516

Invested Capital(Q: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4.825 - 6.686 - ( 0.295 - max(0, 9.113 - 1.993+0.295))
=5.259

Note: The Operating Income data used here is two times the semi-annual (Dec. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

G Medical Innovations Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2022 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2022  Q: Dec. 2022
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1.998/( ( (4.048 + max(-6.265, 0)) + (2.647 + max(-5.957, 0)) )/ 2 )
=-1.998/( ( 4.048 + 2.647 )/ 2 )
=-1.998/3.3475
=-59.69 %

where Working Capital is:

Working Capital(Q: Jun. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.566 + 2.338 + 0.171) - (5.457 + 0 + 3.883)
=-6.265

Working Capital(Q: Dec. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.593 + 0.292 + 0.462) - (6.686 + 0 + 0.618)
=-5.957

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

G Medical Innovations Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2022 )
=-9.864/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G Medical Innovations Holdings EBIT Related Terms

G Medical Innovations Holdings EBIT Historical Data

* Premium members only.

The historical data trend for G Medical Innovations Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G Medical Innovations Holdings EBIT Chart

G Medical Innovations Holdings Annual Data
Trend Sep16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBIT
Get a 7-Day Free Trial -16.33 -12.52 -11.96 -10.10 -9.86

G Medical Innovations Holdings Semi-Annual Data
Sep16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.53 -3.83 -6.27 -8.87 -1.00

GMVDF vs WHSI, ISRG, BDX: EBIT Comparison

For the Medical Devices subindustry, G Medical Innovations Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G Medical Innovations Holdings EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, G Medical Innovations Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where G Medical Innovations Holdings's EV-to-EBIT falls into.


GMVDF
12GF Score
G Medical Innovations Holdings Ltd GMVDF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

G Medical Innovations Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-9.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-9.86 Mil mean?
G Medical Innovations Holdings (GMVDF) has a EBIT of $-9.86 Mil as of Dec. 2022. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on G Medical Innovations Holdings.
Is G Medical Innovations Holdings' EBIT too high?
G Medical Innovations Holdings' current EBIT is $-9.86 Mil. Overall, G Medical Innovations Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does G Medical Innovations Holdings' EBIT compare to WHSI and ISRG?
G Medical Innovations Holdings' EBIT of $-9.86 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on G Medical Innovations Holdings. G Medical Innovations Holdings's current EBIT is $-9.86 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is G Medical Innovations Holdings stock overvalued right now?
G Medical Innovations Holdings (GMVDF) has a current EBIT of $-9.86 Mil. The current EBIT is $-9.86 Mil. G Medical Innovations Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For G Medical Innovations Holdings (GMVDF), the current EBIT is $-9.86 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

G Medical Innovations Holdings Business Description

Address 5 Oppenheimer Street, Rehovot, ISR, 7670105
G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.
12GF Score

Get the complete analysis for GMVDF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price